{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:19:26Z","timestamp":1790162366175,"version":"4.1.0"},"reference-count":59,"publisher":"BMJ","issue":"7","funder":[{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1136\/jnnp-2016-314495","type":"journal-article","created":{"date-parts":[[2017,3,12]],"date-time":"2017-03-12T01:10:27Z","timestamp":1489281027000},"page":"557-563","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":115,"title":["The changing picture of amyotrophic lateral sclerosis: lessons from European registers"],"prefix":"10.1136","volume":"88","author":[{"given":"Orla","family":"Hardiman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"Al-Chalabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Brayne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore","family":"Beghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonard H","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Chio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Logroscino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Rooney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,3,11]]},"reference":[{"key":"key-10.1136\/jnnp-2016-314495-1","first-page":"1150","article-title":"The epidemiology of ALS and the role of population-based registries","author":"Beghi","year":"1762","journal-title":"Biochim Biophys Acta"},{"key":"key-10.1136\/jnnp-2016-314495-2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/jnnp.2009.183525","article-title":"Incidence of amyotrophic lateral sclerosis in Europe","volume":"81","author":"Logroscino","year":"2010","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2016-314495-3","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/ng.3626","article-title":"NEK1 variants confer susceptibility to amyotrophic lateral sclerosis","volume":"48","author":"Kenna","year":"2016","journal-title":"Nat Genet"},{"key":"key-10.1136\/jnnp-2016-314495-4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1186\/s12913-015-1229-x","article-title":"Patient journey to a specialist amyotrophic lateral sclerosis multidisciplinary clinic: an exploratory study","volume":"15","author":"Galvin","year":"2015","journal-title":"BMC Health Serv Res"},{"key":"key-10.1136\/jnnp-2016-314495-5","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S1474-4422(14)70219-4","article-title":"Analysis of amyotrophic lateral sclerosis as a multistep process: a population-based modelling study","volume":"13","author":"Al-Chalabi","year":"2014","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/jnnp-2016-314495-6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/aje\/kws015","article-title":"Smoking, alcohol consumption, and the risk of amyotrophic lateral sclerosis: a population-based study","volume":"176","author":"de Jong","year":"2012","journal-title":"Am J Epidemiol"},{"key":"key-10.1136\/jnnp-2016-314495-7","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1136\/jnnp-2012-304701","article-title":"Evidence of multidimensionality in the ALSFRS-R Scale: a critical appraisal on its measurement properties using Rasch analysis","volume":"84","author":"Franchignoni","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2016-314495-8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000177032","article-title":"Geographical clustering of amyotrophic lateral sclerosis in South-East England: a population study","volume":"32","author":"Scott","year":"2009","journal-title":"Neuroepidemiology"},{"key":"key-10.1136\/jnnp-2016-314495-9","doi-asserted-by":"crossref","first-page":"58","DOI":"10.3109\/21678421.2012.733401","article-title":"Amyotrophic lateral sclerosis in Piedmont (Italy): a Bayesian spatial analysis of the incident cases","volume":"14","author":"Migliaretti","year":"2013","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"key-10.1136\/jnnp-2016-314495-10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.envres.2015.06.024","article-title":"Social deprivation and population density are not associated with small area risk of amyotrophic lateral sclerosis","volume":"142","author":"Rooney","year":"2015","journal-title":"Environ Res"},{"key":"key-10.1136\/jnnp-2016-314495-11","doi-asserted-by":"crossref","first-page":"00","DOI":"10.1371\/journal.pone.0074733","article-title":"Survival analysis of irish amyotrophic lateral sclerosis patients diagnosed from 1995\u20132010","volume":"8","author":"Rooney","year":"2013","journal-title":"PLoS One"},{"key":"key-10.1136\/jnnp-2016-314495-12","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/jnnp.2011.244939","article-title":"Population based epidemiology of amyotrophic lateral sclerosis using capture-recapture methodology","volume":"82","author":"Huisman","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2016-314495-13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000351153","article-title":"Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature","volume":"41","author":"Chi\u00f2","year":"2013","journal-title":"Neuroepidemiology"},{"key":"key-10.1136\/jnnp-2016-314495-14","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1212\/01.wnl.0000343008.26874.d1","article-title":"Epidemiology of ALS in Italy: a 10-year prospective population-based study","volume":"72","author":"Chi\u00f2","year":"2009","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314495-15","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00415-010-5494-7","article-title":"Validating population-based registers for ALS: how accurate is death certification?","volume":"257","author":"Yeo","year":"2010","journal-title":"J Neurol"},{"key":"key-10.1136\/jnnp-2016-314495-16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/17482968.2011.593037","article-title":"Changing incidence and subtypes of ALS in Modena, Italy: A 10-years prospective study","volume":"12","author":"Georgoulopoulou","year":"2011","journal-title":"Amyotroph Lateral Scler"},{"key":"key-10.1136\/jnnp-2016-314495-17","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1212\/01.wnl.0000336653.65605.ac","article-title":"Increasing incidence of ALS in Canterbury, New Zealand: a 22-year study","volume":"71","author":"Murphy","year":"2008","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314495-18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000070563","article-title":"Incidence of amyotrophic lateral sclerosis in the local health district of\u00a0Ferrara, Italy, 1964\u20131998","volume":"22","author":"Govoni","year":"2003","journal-title":"Neuroepidemiology"},{"key":"key-10.1136\/jnnp-2016-314495-19","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1474-4422(12)70014-5","article-title":"Cognitive and clinical characteristics of patients with amyotrophic lateral sclerosis carrying a C9orf72 repeat expansion: a population-based cohort study","volume":"11","author":"Byrne","year":"2012","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/jnnp-2016-314495-20","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/156720511795563700","article-title":"FTD and ALS: a tale of two diseases","volume":"8","author":"Ferrari","year":"2011","journal-title":"Curr Alzheimer Res"},{"key":"key-10.1136\/jnnp-2016-314495-21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jnnp-2011-300472","article-title":"Non-invasive ventilation in amyotrophic lateral sclerosis: a 10 year population based study","volume":"83","author":"Chi\u00f2","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2016-314495-22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s13311-015-0336-z","article-title":"Being PRO-ACTive: what can a clinical trial database reveal about ALS?","volume":"12","author":"Zach","year":"2015","journal-title":"Neurotherapeutics"},{"key":"key-10.1136\/jnnp-2016-314495-23","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1212\/WNL.0b013e318232ab9b","article-title":"ALS clinical trials: do enrolled patients accurately represent the ALS population?","volume":"77","author":"Chi\u00f2","year":"2011","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314495-24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S1474-4422(13)70037-1","article-title":"Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial","volume":"12","author":"Morrison","year":"2013","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/jnnp-2016-314495-25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/jnnp.2007.117788","article-title":"Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004","volume":"79","author":"O'Toole","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2016-314495-26","first-page":"1265","article-title":"Age-period-cohort analysis of trends in amyotrophic lateral sclerosis incidence","volume":"178","author":"Tobin","year":"2016","journal-title":"J Neurol"},{"key":"key-10.1136\/jnnp-2016-314495-27","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00415-016-8313-y","article-title":"Factors predicting survival in ALS: a multicenter Italian\u00a0study","volume":"264","author":"Calvo","year":"2017","journal-title":"J Neurol"},{"key":"key-10.1136\/jnnp-2016-314495-28","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/jnnp-2011-300188","article-title":"The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study","volume":"83","author":"Phukan","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2016-314495-29","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1212\/WNL.0b013e318214359f","article-title":"Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia","volume":"76","author":"Elamin","year":"2011","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314495-30","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1212\/WNL.0b013e31828f18ac","article-title":"Cognitive changes predict functional decline in ALS: a population-based longitudinal study","volume":"80","author":"Elamin","year":"2013","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314495-31","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s00415-014-7612-4","article-title":"Association of IgM monoclonal gammopathy with progressive muscular atrophy and multifocal motor neuropathy: a case-control study","volume":"262","author":"Vlam","year":"2015","journal-title":"J Neurol"},{"key":"key-10.1136\/jnnp-2016-314495-32","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1002\/ana.23969","article-title":"Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: a population-based case-control cohort study of familial and sporadic amyotrophic lateral sclerosis","volume":"74","author":"Byrne","year":"2013","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2016-314495-33","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/jamaneurol.2015.1584","article-title":"Effect of presymptomatic body mass index and consumption of fat and alcohol on amyotrophic lateral sclerosis","volume":"72","author":"Huisman","year":"2015","journal-title":"JAMA Neurol"},{"key":"key-10.1136\/jnnp-2016-314495-34","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1136\/jnnp-2012-304724","article-title":"Lifetime physical activity and the risk of amyotrophic lateral sclerosis","volume":"84","author":"Huisman","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2016-314495-35","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3109\/17482960802430799","article-title":"What we truly know about occupation as a risk factor for ALS: a critical and systematic review","volume":"10","author":"Sutedja","year":"2009","journal-title":"Amyotroph Lateral Scler"},{"key":"key-10.1136\/jnnp-2016-314495-36","first-page":"1","article-title":"Critical issues in ALS case-control studies: the case of the Euro-MOTOR study","author":"D\u2019Ovidio","year":"2017","journal-title":"Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration"},{"key":"key-10.1136\/jnnp-2016-314495-37","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/aje\/kwv095","article-title":"Geographic Variation of Amyotrophic Lateral Sclerosis Incidence in New Jersey, 2009-2011","volume":"182","author":"Henry","year":"2015","journal-title":"Am J Epidemiol"},{"key":"key-10.1136\/jnnp-2016-314495-38","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1136\/bmj.313.7061.863","article-title":"Cluster analysis and disease mapping--why, when, and how? A step by step guide","volume":"313","author":"Olsen","year":"1996","journal-title":"BMJ"},{"key":"key-10.1136\/jnnp-2016-314495-39","first-page":"1","article-title":"Incidence of amyotrophic lateral sclerosis in the province of Novara, Italy, and possible role of environmental pollution","author":"Tesauro","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"key-10.1136\/jnnp-2016-314495-40","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1212\/WNL.0000000000001477","article-title":"Spatial cluster analysis of population amyotrophic lateral sclerosis risk in Ireland","volume":"84","author":"Rooney","year":"2015","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314495-41","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/jnnp.2010.224501","article-title":"Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"82","author":"Byrne","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2016-314495-42","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1007\/s00415-012-6681-5","article-title":"Amyotrophic lateral sclerosis in Sardinia, insular Italy, 1995-2009","volume":"260","author":"Pugliatti","year":"2013","journal-title":"J Neurol"},{"key":"key-10.1136\/jnnp-2016-314495-43","doi-asserted-by":"crossref","first-page":"2882.e7","DOI":"10.1016\/j.neurobiolaging.2014.07.012","article-title":"Genetic architecture of ALS in Sardinia","volume":"35","author":"Borghero","year":"2014","journal-title":"Neurobiol Aging"},{"key":"key-10.1136\/jnnp-2016-314495-44","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S1474-4422(12)70043-1","article-title":"Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study","volume":"11","author":"Majounie","year":"2012","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/jnnp-2016-314495-45","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/jmedgenet-2013-101795","article-title":"Delineating the genetic heterogeneity of ALS using targeted high-throughput sequencing","volume":"50","author":"Kenna","year":"2013","journal-title":"J Med Genet"},{"key":"key-10.1136\/jnnp-2016-314495-46","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/jnnp.2006.104828","article-title":"Descriptive epidemiology of amyotrophic lateral sclerosis: new evidence and unsolved issues","volume":"79","author":"Logroscino","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2016-314495-47","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1212\/WNL.0b013e3181a55f7b","article-title":"Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study","volume":"72","author":"Zaldivar","year":"2009","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314495-48","doi-asserted-by":"crossref","first-page":"dyw061","DOI":"10.1093\/ije\/dyw061","article-title":"Variation in worldwide incidence of amyotrophic lateral sclerosis: a meta-analysis","volume":"89","author":"Marin","year":"2016","journal-title":"Int J Epidemiol"},{"key":"key-10.1136\/jnnp-2016-314495-49","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10654-015-0090-x","article-title":"Clinical and demographic factors and outcome of amyotrophic lateral sclerosis in relation to population ancestral origin","volume":"31","author":"Marin","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"key-10.1136\/jnnp-2016-314495-50","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3109\/21678421.2013.852590","article-title":"Amyotrophic lateral sclerosis: analysis of ALS cases in a predominantly admixed population of Ecuador","volume":"15","author":"Bucheli","year":"2014","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"key-10.1136\/jnnp-2016-314495-51","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1161\/STR.0b013e3182213e24","article-title":"Racial-ethnic disparities in stroke care: the American experience: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"42","author":"Cruz-Flores","year":"2011","journal-title":"Stroke"},{"key":"key-10.1136\/jnnp-2016-314495-52","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.2105\/AJPH.2015.302903a","article-title":"Implicit racial\/ethnic bias among health care professionals and its influence on health care outcomes: a systematic review","volume":"105","author":"Hall","year":"2015","journal-title":"Am J Public Health"},{"key":"key-10.1136\/jnnp-2016-314495-53","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/jnnp-2014-309601","article-title":"A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and northern Ireland","volume":"86","author":"Rooney","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2016-314495-54","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00415-006-0401-y","article-title":"ALS multidisciplinary clinic and survival. results from a population-based study in southern Italy","volume":"254","author":"Zoccolella","year":"2007","journal-title":"J Neurol"},{"key":"key-10.1136\/jnnp-2016-314495-55","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1212\/01.wnl.0000180717.29273.12","article-title":"Multidisciplinary ALS care improves quality of life in patients with ALS","volume":"65","author":"Van den Berg","year":"2005","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2016-314495-56","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/jnnp.2005.083402","article-title":"Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities","volume":"77","author":"Chio","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.1136\/jnnp-2016-314495-57","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/17482960802103131","article-title":"The costs of amyotrophic lateral sclerosis, according to type of care","volume":"10","author":"van der Steen","year":"2009","journal-title":"Amyotroph Lateral Scler"},{"key":"key-10.1136\/jnnp-2016-314495-58","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jval.2011.12.010","article-title":"Prospective observational studies to assess comparative effectiveness: the ISPOR good research practices task force report","volume":"15","author":"Berger","year":"2012","journal-title":"Value Health"},{"key":"key-10.1136\/jnnp-2016-314495-59","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00415-003-1026-z","article-title":"An outcome study of riluzole in amyotrophic lateral sclerosis-a population-based study in Ireland, 1996\u20132000","volume":"250","author":"Traynor","year":"2003","journal-title":"J Neurol"}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2016-314495","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T18:04:01Z","timestamp":1601057041000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2016-314495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,11]]},"references-count":59,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2017,8,17]]},"published-print":{"date-parts":[[2017,7]]}},"alternative-id":["10.1136\/jnnp-2016-314495"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2016-314495","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,11]]}}}